0001104659-23-036164.txt : 20230323
0001104659-23-036164.hdr.sgml : 20230323
20230323200932
ACCESSION NUMBER: 0001104659-23-036164
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230321
FILED AS OF DATE: 20230323
DATE AS OF CHANGE: 20230323
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HOGUE GERALD L.
CENTRAL INDEX KEY: 0001868738
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39373
FILM NUMBER: 23757485
MAIL ADDRESS:
STREET 1: 4850 WEST 78TH STREET
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46268
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: POINT Biopharma Global Inc.
CENTRAL INDEX KEY: 0001811764
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 850800493
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4850 WEST 78TH STREET
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46268
BUSINESS PHONE: (317) 543-9957
MAIL ADDRESS:
STREET 1: 4850 WEST 78TH STREET
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46268
FORMER COMPANY:
FORMER CONFORMED NAME: Therapeutics Acquisition Corp.
DATE OF NAME CHANGE: 20200511
4
1
tm2310415-1_4seq1.xml
OWNERSHIP DOCUMENT
X0407
4
2023-03-21
0
0001811764
POINT Biopharma Global Inc.
PNT
0001868738
HOGUE GERALD L.
4850 WEST 78TH STREET
INDIANAPOLIS
IN
46268
1
0
0
0
0
Common Stock
2023-03-21
4
M
0
17936
6.97
A
21596
D
Stock Option (Right to Buy)
6.97
2023-03-21
4
M
0
17936
0
D
2026-12-01
Common Stock
17936
17936
D
As previously reported in a Form 4 filed with the Securities and Exchange Commission on June 30, 2021, the reporting person received an option to purchase 35,872 shares of the issuer's common stock (the "Option"). The Option vested 25% on December 1, 2021 and 25% on December 1, 2022, and will vest 25% on December 1, 2023 and 25% on December 1, 2024.
/s/ William L. Demers, by Power of Attorney for Gerald L. Hogue
2023-03-23